| VU shunt | Ventriculo-Ureteral shunt |
|---|---|
| SP | sacroposterior; sacrum to pubis; salivary progesterone; schizotypal personality; semi-private [room]... |
| PEEP | Positive End-Expiratory Pressure ? Ix 1. PaO2 < 60 mmHg, ... |
| TIPSS | Transjugular Intrahepatic Portosystemic Stant, Shunt |
| AVS | aortic valve stenosis; arteriovenous shunt; auditory vocal sequencing |
| metabolic encephalopathy | Encephalopathy characterised by memory loss, vertigo, and generalised weakness, due to metabolic brain disease including hypoxia, ischemia, hypoglycaemia, or secondary to other organ failure such as liver or kidney. (05 Mar 2000) |
|---|---|
| metabolic equivalent | The oxygen cost of energy expenditure measured at supine rest (1 MET = 3.5 ml O2 per kg of body weight per minute); multiples of MET are used to estimate the oxygen cost of activity, e.g., 3 to 5 METs for light work; more than 9 METs for heavy work. (05 Mar 2000) |
| metabolic indican | 1. <chemistry> A glucoside obtained from woad (indigo plant) and other plants, as a yellow or light brown sirup. It has a nauseous bitter taste, a decomposes or drying. By the action of acids, ferments, etc, it breaks down into sugar and indigo. It is the source of natural indigo. 2. <physiology> An indigo-forming substance, found in urine, and other animal fluids, and convertible into red and blue indigo (urrhodin and uroglaucin). Chemically, it is indoxyl sulphate of potash, C8H6NSO4K, and is derived from the indol formed in the alimentary canal. Synonym: uroxanthin. See: Indigo. Source: Websters Dictionary (01 Mar 1998) |
| metabolic mucinosis | Diffuse or pretibial myxoedema, lichen myxoedematosus, gargoylism, secondary mucinosis, degeneration in tumours, localised mucinosis, follicular, papular, plaque-like, focal, and myxoid or synovial cyst. Origin: mucin + G. -osis, condition (05 Mar 2000) |
| metabolic pool | The quantity of a given chemical compound or group of related compounds participating in metabolic reactions; may constitute only a portion of the total bodily content of such compounds. (05 Mar 2000) |
| compensated metabolic alkalosis | The retention of acid, primarily carbon dioxide by the lung and acid ions by the renal tubules, to reduce the effect on the pH of the blood of excess alkali produced by ingestion or metabolism of alkali-producing substances. (05 Mar 2000) |
| skin diseases, metabolic | Diseases of the skin associated with underlying metabolic disorders. (12 Dec 1998) |
| steroid metabolic clearance rate | A measure of the rate of metabolism of a given steroid within the body, usually expressed as liters of body fluid that contain the amount of steroid metabolised per day. (05 Mar 2000) |
| nutritional and metabolic diseases | A collective term for nutritional disorders (result of poor assimilation or utilization of food) and metabolic disorders (result of poor metabolism or inherited enzyme abnormality). (12 Dec 1998) |
| arteriovenous shunt | <anatomy, surgery> A direct connection between an artery and vein. Most often due to the surgical joining of an artery and a vein under the skin for the purpose of haemodialysis. Larger arteriovenous shunts can create significant extra workload on the heart since arterial blood is diverted back to the venous circulation before it has a chance to deliver nutrients and oxygen to the body tissues. (20 Jun 2000) |
| A-V shunt | <anatomy, surgery> A direct connection between an artery and vein. Most often due to the surgical joining of an artery and a vein under the skin for the purpose of haemodialysis. Larger arteriovenous shunts can create significant extra workload on the heart since arterial blood is diverted back to the venous circulation before it has a chance to deliver nutrients and oxygen to the body tissues. (20 Jun 2000) |
| Blalock shunt | Subclavian artery to pulmonary artery shunt to increase pulmonary circulation in cyanotic heart disease with decreased pulmonary flow. (05 Mar 2000) |
| Blalock-Taussig shunt | A palliative subclavian artery to pulmonary artery anastomosis. (05 Mar 2000) |
| Rapoport-Luebering shunt | Part of the glycolytic pathway characteristic of human erythrocytes in which 2,3-bisphosphoglycerate (2,3-P2Gri) is formed as an intermediate between 1,3-P2Gri and 3-phosphoglycerate; 2,3-P2Gri is an important regulator of the affinity of haemoglobin for oxygen. (05 Mar 2000) |
| ventriculoperitoneal shunt | <procedure> A surgical procedure to insert a communicating catheter to relieve intracranial pressure caused by hydrocephalus. In this procedure the cerebrospinal fluid is shunted from the ventricles of the brain into the peritoneal cavity via a surgically implanted tube. (27 Sep 1997) |